Catherine Bingchan Xie

Catherine Bingchan Xie

Auto-generated profile, based on publicly available information

Catherine Bingchan Xie

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Tissue Engineering Part A
Verified
Journal Article
Closed access
TBTânia Baltazar
Tânia Baltazar
JMJonathan Merola
Jonathan Merola
CCCarolina Motter Catarino
Carolina Motter Catarino
CXCatherine Bingchan Xie
Catherine Bingchan Xie
NKNancy C. Kirkiles-Smith
Nancy C. Kirkiles-Smith
PKPankaj Karande
Pankaj Karande
Multilayered skin substitutes comprising allogeneic cells have been tested for the treatment of non-healing cutaneous ulcers. However, such non-native skin grafts fail to permanently engraft because they lack dermal vascular networks important for integration with the host tissue. Here we describe the fabrication of an implantable multi-layered vascularized bioengineered skin graft using 3D bioprinting. The graft is formed using one bioink containing human foreskin dermal fibroblasts (FBs), human endothelial cells (ECs) derived from cord blood human endothelial colony forming cells (HECFCs), and human placental pericytes (PCs) suspended in rat tail type I collagen to form a dermis followed by printing with a second bioink containing human foreskin keratinocytes (KCs) to form an epidermis. In vitro, KCs replicate and mature to form a multilayered barrier while the ECs and PCs self-assemble into interconnected microvascular networks. The PCs in the dermal bioink associate with EC-lined vascular structures and appear to improve KC maturation. When these 3D printed grafts are implanted on the dorsum of immunodeficient mice, the human EC-lined structures inosculate with mouse microvessels arising from the wound bed and become perfused within 4 weeks after implantation. The presence of PCs in the printed dermis enhances the invasion of the graft by host microvessels and the formation of an epidermal rete.

16 March 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
CXCatherine B. Xie
Catherine B. Xie
DJDan Jane-Wit
Dan Jane-Wit
JPJordan S. Pober
Jordan S. Pober

7 June 2019 in Circulation Research
Verified
Journal Article
Closed access
PDF file
CXCatherine B. Xie
Catherine B. Xie
LQLingfeng Qin
Lingfeng Qin
GLGuangxin Li
Guangxin Li
CFCaodi Fang
Caodi Fang
NKNancy C. Kirkiles-Smith
Nancy C. Kirkiles-Smith
DJDan Jane-wit
Dan Jane-wit
Rationale:: Complement activation contributes to multiple immune-mediated pathologies. In late allograft failure, donor-specific antibody deposits complement membrane attack complexes (MAC) on graft endothelial cells (ECs), substantially increasing their immunogenicity without causing lysis. Internalized MAC stabilize NIK (NF-κB [nuclear factor kappa-light-chain-enhancer of activated B cells]–inducing kinase) protein on Rab5+MAC+ endosomes, activating noncanonical NF-κB signaling. However, the link to increased immunogenicity is unclear. Objective:: To identify mechanisms by which alloantibody and internalized MAC activate ECs to enhance their ability to increase T-cell responses. Methods and Results:: In human EC cultures, internalized MAC also causes NLRP3 (NOD-like receptor family pyrin domain containing 3) translocation from endoplasmic reticulum to Rab5+MAC+NIK+ endosomes followed by endosomal NIK-dependent inflammasome assembly. Cytosolic NIK, stabilized by LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells), does not trigger inflammasome assembly, and ATP-triggered inflammasome assembly does not require NIK. IFN-γ (interferon-γ) primes EC responsiveness to MAC by increasing NLRP3, pro-caspase 1, and gasdermin D expression. NIK-activated noncanonical NF-κB signaling induces pro-IL (interleukin)-1β expression. Inflammasome processed pro-IL-1β, and gasdermin D results in IL-1β secretion that increases EC immunogenicity through IL-1 receptor signaling. Activation of human ECs lining human coronary artery grafts in immunodeficient mouse hosts by alloantibody and complement similarly depends on assembly of an NLRP3 inflammasome. Finally, in renal allograft biopsies showing chronic rejection, caspase-1 is activated in C4d + ECs of interstitial microvessels, supporting the relevance of the cell culture findings. Conclusions:: In response to antibody-mediated complement activation, IFN-γ-primed human ECs internalize MAC, triggering both endosomal-associated NIK-dependent NLRP3 inflammasome assembly and IL-1 synthesis, resulting in autocrine/paracrine IL-1β-mediated increases in EC immunogenicity. Similar responses may underlie other complement-mediated pathologies.

7 September 2012 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
RKRussell S. Komor
Russell S. Komor
PRPhilip A. Romero
Philip A. Romero
CXCatherine B. Xie
Catherine B. Xie
FAFrances H. Arnold
Frances H. Arnold
Building on our previous efforts to generate thermostable chimeric fungal cellobiohydrolase I (CBH I, also known as Cel7A) cellulases by structure-guided recombination, we used FoldX and a ‘consensus’ sequence approach to identify individual mutations present in the five homologous parent CBH I enzymes which further stabilize the chimeras. Using the FoldX force field, we calculated the effect on ΔGFolding of each candidate mutation in a number of CBH I structures and chose those predicted to be stabilizing in multiple structures. With an alignment of 41 CBH I sequences, we also used amino acid frequencies at each candidate position to calculate predicted effects on ΔGFolding. A combination of mutations chosen using these methods increased the T50 of the most thermostable chimera by an additional 4.7°C, to yield a CBH I with T50 of 72.1°C, which is 9.2°C higher than that of the most stable native CBH I, from Talaromyces emersonii. This increased stability resulted in a 10°C increase in the optimal temperature for activity, to 65°C, and a 50% increase in total sugar production from crystalline cellulose at the optimal temperature, compared with native T.emersonii CBH I.

28 August 2014 in Blood
Verified
Journal Article
Open access
PDF file
ASAlex Yick-Lun So
Alex Yick-Lun So
RSReeshelle Sookram
Reeshelle Sookram
ACAadel A. Chaudhuri
Aadel A. Chaudhuri
AMAarathi Minisandram
Aarathi Minisandram
DCDavid Cheng
David Cheng
DBDavid Baltimore
David Baltimore
Key Points: MiR-125b induces tumorigenesis in myeloid cells by repressing the expression of IRF4 at the mRNA and protein level. MiR-125b promotes oncogenesis in B cells that involves selection of cells that acquire genetic deletion of the gene encoding IRF4.

11 February 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
LLLufang Liu
Lufang Liu
CFCaodi Fang
Caodi Fang
WFWhitney Fu
Whitney Fu
BJBo Jiang
Bo Jiang
GLGuangxin Li
Guangxin Li
DJDan Jane-wit
Dan Jane-wit
Background: Ischemia reperfusion injury (IRI) predisposes to the formation of donor-specific antibodies, a factor contributing to chronic rejection and late allograft loss. Methods: We describe a mechanism underlying the correlative association between IRI and donor-specific antibodies by using humanized models and patient specimens. Results: IRI induces immunoglobulin M–dependent complement activation on endothelial cells that assembles an NLRP3 (NOD-like receptor pyrin domain-containing protein 3) inflammasome via a Rab5-ZFYVE21-NIK axis and upregulates ICOS-L (inducible costimulator ligand) and PD-L2 (programmed death ligand 2). Endothelial cell–derived interleukin-18 (IL-18) selectively expands a T-cell population (CD4+CD45RO+PD-1 hi ICOS+CCR2+CXCR5–) displaying features of recently described T peripheral helper cells. This population highly expressed IL-18R1 and promoted donor-specific antibodies in response to IL-18 in vivo. In patients with delayed graft function, a clinical manifestation of IRI, these cells were Ki-67+IL-18R1+ and could be expanded ex vivo in response to IL-18. Conclusions: IRI promotes elaboration of IL-18 from endothelial cells to selectively expand alloreactive IL-18R1+ T peripheral helper cells in allograft tissues to promote donor-specific antibody formation.